Literature DB >> 2400205

Iron deficiency in growing male rats: a cause of development of cardiomyopathy.

D H Petering1, K L Stemmer, S Lyman, S Krezoski, H G Petering.   

Abstract

Weanling male rats were fed a purified iron-adequate, a purified iron-deficient or a commercial diet for 12 weeks. At that time the rats were sacrificed, their hearts and livers were excised, and blood samples were taken. Heart and liver weights were recorded; organ tissue and serum samples were analyzed for Zn, Cu and Fe. Hemoglobin and hematocrit values were also obtained. The iron-deficient rats grew much more slowly than controls on the iron-adequate or commercial diets. The iron-deficient rats were severely anemic and had enlarged hearts (cardiomegaly). A histopathologic examination of the hearts of all animals showed that each heart of the iron-deficient rats had lesions characteristic of cardiomyopathy by dilatation, whereas none of the hearts of the iron-adequate group or the chow controls showed any lesions at all. The iron-deficient animals had only about 25% of the hepatic iron found in the iron-adequate animals but about 5 times the hepatic copper of the latter group or the chow controls. Heart iron of the iron-deficient group was 27% of the concentration found in hearts of the iron-adequate rats; heart copper was similar in all groups. Animals on the commercial stock diet accumulated significantly more iron in their hearts than did those on the purified iron-adequate diet but not in the livers. There was also a direct correlation of heart iron or heart zinc with log concentrations of dietary iron and consequently a direct correlation between heart iron and zinc concentrations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2400205     DOI: 10.1159/000177592

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  6 in total

1.  The cardiomyopathy of iron deficiency.

Authors:  Nikita Hegde; Michael W Rich; Charina Gayomali
Journal:  Tex Heart Inst J       Date:  2006

2.  Iron and copper in mitochondrial diseases.

Authors:  Wenjing Xu; Tomasa Barrientos; Nancy C Andrews
Journal:  Cell Metab       Date:  2013-03-05       Impact factor: 27.287

3.  Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure.

Authors:  Gregory D Lewis; Marc J Semigran; Michael M Givertz; Rajeev Malhotra; Kevin J Anstrom; Adrian F Hernandez; Monica R Shah; Eugene Braunwald
Journal:  Circ Heart Fail       Date:  2016-05       Impact factor: 8.790

4.  Lethal Cardiomyopathy in Mice Lacking Transferrin Receptor in the Heart.

Authors:  Wenjing Xu; Tomasa Barrientos; Lan Mao; Howard A Rockman; Anthony A Sauve; Nancy C Andrews
Journal:  Cell Rep       Date:  2015-10-08       Impact factor: 9.423

5.  Iron-Deficiency Anemia Results in Transcriptional and Metabolic Remodeling in the Heart Toward a Glycolytic Phenotype.

Authors:  Yu Jin Chung; Pawel Swietach; M Kate Curtis; Vicky Ball; Peter A Robbins; Samira Lakhal-Littleton
Journal:  Front Cardiovasc Med       Date:  2021-01-21

Review 6.  Structural and functional abnormalities in iron-depleted heart.

Authors:  Kamil A Kobak; Malwina Radwańska; Magdalena Dzięgała; Monika Kasztura; Krystian Josiak; Waldemar Banasiak; Piotr Ponikowski; Ewa A Jankowska
Journal:  Heart Fail Rev       Date:  2019-03       Impact factor: 4.214

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.